Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Pdmp topic
No spam. Unsubscribe anytime.
Committee fixes PDMP statute to explicitly include podiatrists
Summary
The Public Health, Welfare and Labor Committee voted to pass House Bill 10‑13, which corrects a 2017 omission by adding podiatrists to the list of prescribers required to check the state Prescription Drug Monitoring Program before prescribing certain controlled substances.
Representative Justin Boyd, R‑District 77, told the Senate Public Health, Welfare and Labor Committee that House Bill 10‑13 corrects a drafting error from 2017 that left podiatrists off the list of prescribers required to check the state Prescription Drug Monitoring Program (PDMP) before writing a Schedule II narcotic or a first‑time benzodiazepine. "When that bill was written, somehow, podiatrists were inadvertently left off," Boyd said, urging committee support.
Boyd said the House passed the original measure nearly unanimously and that he had not been contacted by any opponents. Committee members asked whether the committee had checked for other similar drafting errors; Boyd said he had reviewed the language personally and asked the podiatry board to adopt a rule in the meantime but preferred the statutory fix so future changes require legislative review.
A senator moved to pass the bill, the committee voted "aye," and the chair announced that the bill passed out of committee.
The change is procedural and narrowly focused: it brings podiatrists into parity with other prescriptive boards for PDMP checks. Committee discussion did not identify organized opposition or changes to the scope of the PDMP requirement beyond correcting the omission.
The bill now advances according to the legislative calendar.
